The Technical Analyst
Select Language :
Nexus AG [NXU.DE]

Exchange: XETRA Sector: Healthcare Industry: Health Information Services

Nexus AG Price, Forecast, Insider, Ratings, Fundamentals & Signals

Nexus AG is listed at the  Exchange

1.35% €52.40

Europe/Berlin / 2 mai 2024 @ 16:36


FUNDAMENTALS
MarketCap: 904.67 mill
EPS: 1.390
P/E: 37.70
Earnings Date: May 14, 2024
SharesOutstanding: 17.26 mill
Avg Daily Volume: 0.0043 mill
RATING 2024-05-02
A
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Buy
Return On Asset: Buy
DE: Neutral
P/E: Buy
Price To Book: Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
1.93x
Company: PE 37.70 | sector: PE 19.58
PE RATIO: COMPANY / INDUSTRY
0.92x
Company: PE 37.70 | industry: PE 41.10
DISCOUNTED CASH FLOW VALUE
€50.70
(-3.24%) €-1.699
Date: 2024-05-02
Expected Trading Range (DAY)

€ 51.10 - 53.70

( +/- 2.48%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - €52.40
Forecast 2: 16:00 - €52.40
Forecast 3: 16:00 - €52.40
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price €52.40 (1.35% )
Volume 0.0009 mill
Avg. Vol. 0.0043 mill
% of Avg. Vol 21.10 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Nexus AG

Last 12 Months

Last 12 months chart data with high, low, open and close for Nexus AG

RSI

Last 10 Buy & Sell Signals For NXU.DE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Nexus AG

NXU.DE

Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; dc-Pathos and dc-LabMan for pathology and cytology devices; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/PAT, an administration system for hospitals; and osoTEC for billing personal and other services. In addition, the company offers SINAPSI, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, and NEXUS/ESKULAP. NEXUS AG is headquartered in Donaueschingen, Germany.

Last 10 Buy Signals

Date Signal @
SRPTMay 2 - 11:16$133.68
CHRDMay 2 - 11:15175.52
AXNXMay 2 - 11:14$66.85
HGUSDMay 2 - 11:11$4.48
CHRWMay 2 - 11:04$83.83
RXRXMay 2 - 11:02$8.37
HBTCUSDMay 2 - 11:0024 472
LEOUSDMay 2 - 10:555.89
EXCMay 2 - 10:55$37.52
ITCIMay 2 - 10:53$72.12

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.